Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sutent in advanced pancreatic islet cell tumors
NCT00428597Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Jun 2007
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of sunitinib in pancreatic islet cell tumor (pNET), sponsored by Pfizer. Started Jun 2007; status: terminated.
02
Drugs
sunitinib
03
Conditions
pancreatic islet cell tumor (pNET)
Beyond the preview
Go deeper on NCT00428597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00428597.